Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Entera Bio Ltd.

    NASDAQ: ENTX · Real-Time Price · USD
    1.86
    -0.23 (-11.00%)
    At close: Jun 13, 2025, 3:59 PM
    1.86
    0.00%
    After-hours: Jun 13, 2025, 04:04 PM EDT

    Entera Bio Statistics

    Share Statistics

    Entera Bio has 45.45M shares outstanding. The number of shares has increased by 16.52% in one year.

    Shares Outstanding

    n/a
    		 45.45M

    Shares Change (YoY)

    n/a
    		 16.52%

    Shares Change (QoQ)

    n/a
    		 13.31%

    Owned by Institutions (%)

    n/a
    		 19.95%

    Shares Floating

    n/a
    		 32M

    Failed to Deliver (FTD) Shares

    n/a
    		 426

    FTD / Avg. Volume

    n/a
    		 1.05%

    Short Selling Information

    The latest short interest is 79.2K, so 0.17% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 79.2K

    Short % of Shares Out

    n/a
    		 0.17%

    Short % of Float

    n/a
    		 0.2%

    Short Ratio (days to cover)

    n/a
    		 1.78

    Valuation Ratios

    The PE ratio is -8.37 and the forward PE ratio is 8.71. Entera Bio's PEG ratio is 0.43.

    PE Ratio

    n/a
    		 -8.37

    Forward PE

    n/a
    		 8.71

    PS Ratio

    n/a
    		 440.99

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 9.88

    P/FCF Ratio

    n/a
    		 -11.7

    PEG Ratio

    n/a
    		 0.43
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Entera Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 7.63

    Quick Ratio

    n/a
    		 7.63

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $10,055.56

    Profits Per Employee

    n/a
    		 $-530,055.56

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 14K

    Effective Tax Rate

    n/a
    		 -0.15%

    Stock Price Statistics

    The stock price has increased by -10.14% in the last 52 weeks. The beta is 1.48, so Entera Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 -10.14%

    50-Day Moving Average

    n/a
    		 1.99

    200-Day Moving Average

    n/a
    		 1.99

    Relative Strength Index (RSI)

    n/a
    		 40.36

    Average Volume (20 Days)

    n/a
    		 40,665

    Income Statement

    In the last 12 months, Entera Bio had revenue of 181K and earned -9.54M in profits. Earnings per share was -0.25.

    Revenue

    n/a
    		 181K

    Gross Profit

    n/a
    		 9K

    Operating Income

    n/a
    		 -9.59M

    Net Income

    n/a
    		 -9.54M

    EBITDA

    n/a
    		 -9.54M

    EBIT

    n/a
    		 -9.59M

    Earnings Per Share (EPS)

    n/a
    		 -0.25
    Full Income Statement

    Balance Sheet

    The company has 8.66M in cash and 272K in debt, giving a net cash position of 8.39M.

    Cash & Cash Equivalents

    n/a
    		 8.66M

    Total Debt

    n/a
    		 272K

    Net Cash

    n/a
    		 8.39M

    Retained Earnings

    n/a
    		 -113.93M

    Total Assets

    n/a
    		 21.6M

    Working Capital

    n/a
    		 19.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.82M and capital expenditures -3K, giving a free cash flow of -6.82M.

    Operating Cash Flow

    n/a
    		 -6.82M

    Capital Expenditures

    n/a
    		 -3K

    Free Cash Flow

    n/a
    		 -6.82M

    FCF Per Share

    n/a
    		 -0.18
    Full Cash Flow Statement

    Margins

    Gross margin is 4.97%, with operating and profit margins of -5295.58% and -5271.27%.

    Gross Margin

    n/a
    		 4.97%

    Operating Margin

    n/a
    		 -5295.58%

    Pretax Margin

    n/a
    		 -5263.54%

    Profit Margin

    n/a
    		 -5271.27%

    EBITDA Margin

    n/a
    		 -5270.17%

    EBIT Margin

    n/a
    		 -5295.58%

    FCF Margin

    n/a
    		 -3768.51%

    Dividends & Yields

    ENTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ENTX is $10, which is 437.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 437.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 14.93

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist